| Serial Number | 97597040 |
| Word Mark | GOLDSPIRE |
| Filing Date | Monday, September 19, 2022 |
| Status | 748 - STATEMENT OF USE - TO EXAMINER |
| Status Date | Tuesday, April 30, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 13, 2024 |
| Pseudo Mark | GOLD SPIRE |
| Goods and Services | Scientific research, design and development of personalized whole tumor-derived cell-based autologous immunotherapies for the treatment of cancers; providing a proprietary technology platform for the development of pharmaceutical products and devices featuring technology capable of eliciting anti-tumor responses via the release of tumor antigenic signatures and immunostimulatory factors that activate the adaptive immune system against tumor cells |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 4, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, December 5, 2022 |
| First Use In Commerce Date | Monday, December 5, 2022 |
| Party Name | Imvax, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Philadelphia, PA 19106 |
| Party Name | Imvax, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Philadelphia, PA 19106 |
| Event Date | Event Description |
| Thursday, September 22, 2022 | NEW APPLICATION ENTERED |
| Tuesday, October 4, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, June 28, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, August 16, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, August 16, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, August 16, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, November 16, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, November 16, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, November 16, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, November 16, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Thursday, November 16, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Thursday, November 16, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Thursday, January 4, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, January 4, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, January 4, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, January 6, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 24, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 13, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 13, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 9, 2024 | USE AMENDMENT FILED |
| Tuesday, April 9, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, April 9, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, April 30, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, April 30, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| Thursday, August 29, 2024 | ASSIGNED TO EXAMINER |